Derivatives of pyridoindole, having anti-tumor properties

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 86, 546 87, C07D47104, A61K 3144

Patent

active

048351601

ABSTRACT:
The present invention concerns derivatives of 5H-pyrido[4,3-b]-indole with the following general formula: ##STR1## in which n represents a whole number from 2 to 4, R.sub.1 represents hydrogen or a lower alkyl group; R.sub.2 represents hydrogen, a hydroxy group or a lower alkyloxy group; R.sub.3 and R.sub.4 represents hydrogen, a lower alkyl group or hydroxyalkyl group, R.sub.5 can be identical or different and represents hydrogen, a hydroxy group or a lower alkyl group, as well as the tautomeric forms and the addition salts with pharmaceutically acceptable mineral or organic acids.
The invention also concerns their preparation process, and their use as medicaments.

REFERENCES:
Nguyen et al., Tetrahedron, vol. 43 (No. 3), pp. 527-535 (Mar. 1 1987).
Chem. Abstracts, vol. 108(7), abst. No. 55,931h, Feb. 15, 1988.
Chem. Abstracts, vol. 108(9), abst. No. 75,380-f, Feb. 29, 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Derivatives of pyridoindole, having anti-tumor properties does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of pyridoindole, having anti-tumor properties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of pyridoindole, having anti-tumor properties will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2152793

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.